Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy

P B Bergqvist1, M Some, G Apelqvist

  • 1Department of Clinical Pharmacology, Lund University Hospital, Sweden.

Pharmacology & Toxicology
|April 1, 1997
PubMed
Summary

Increased brain 5-hydroxytryptophol levels are linked to portal-systemic encephalopathy in rats. This suggests a role for elevated serotonin metabolism in the condition

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations on the measurement and use of the alcohol consumption biomarker CDT. A position paper from the IFCC Working Group on CDT standardisation.

Clinica chimica acta; international journal of clinical chemistry·2024
Same author

Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.

Veterinary journal (London, England : 1997)·2019
Same author

'Is nitrogen mustard contamination responsible for the reported MT-45 toxicity?' Reply from the authors.

The British journal of dermatology·2017
Same author

Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing - a step towards a 'black-box' solution?

Journal of mass spectrometry : JMS·2017
Same author

'Adulterant or contaminant in MT-45, or coingestion?' Reply from the authors.

The British journal of dermatology·2017
Same author

Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.

The British journal of dermatology·2016

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathophysiology

Background:

  • Portal-systemic encephalopathy (PSE) is a complex neurological complication of liver disease.
  • Serotonin metabolism in the brain is altered in various neurological conditions.
  • Understanding serotonin metabolite changes in PSE is crucial for elucidating its pathogenesis.

Purpose of the Study:

  • To investigate brain tissue levels of serotonin metabolites, 5-hydroxytryptophol and 5-hydroxyindole-3-acetic acid (5-HIAA), in a rat model of PSE.
  • To explore the relationship between these metabolites and the development of PSE.
  • To determine if altered serotonin metabolism or redox potential contributes to elevated 5-hydroxytryptophol in PSE.

Main Methods:

  • Utilized porta-caval shunted rats as an in vivo model of PSE.

Related Experiment Videos

  • Measured brain tissue concentrations of 5-hydroxytryptophol and 5-HIAA.
  • Administered L-tryptophan to sham-operated rats to modulate brain serotonin metabolism.

    • Main Results:

    • Porta-caval shunted rats exhibited significantly increased brain levels of 5-hydroxytryptophol (31%) and 5-HIAA (87%) compared to controls.
    • The ratio of 5-hydroxytryptophol to 5-HIAA was reduced in the PSE model.
    • L-tryptophan challenge in sham rats resulted in intermediate 5-hydroxytryptophol levels.

    Conclusions:

    • Elevated brain 5-hydroxytryptophol levels are associated with the pathogenesis of experimental portal-systemic encephalopathy.
    • Increased brain serotonin metabolism, not altered redox potential, likely accounts for higher 5-hydroxytryptophol in PSE.
    • These findings highlight a potential role for serotonin pathway dysregulation in PSE.